| Net Cash Provided by (Used in) Operating Activities |
$646,000 |
USD |
504% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$1,674,000 |
USD |
-885% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$976,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
9,952,950 |
shares |
3.5% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$52,000 |
USD |
45% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$220,000 |
USD |
67% |
Q3 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$110,000 |
USD |
-5.2% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$5,700,000 |
USD |
-3.4% |
Q3 2025 |
Q2 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Gross |
$7,467,000 |
USD |
-8.8% |
Q1 2025 |
FY 2025 |
| Operating Lease, Liability |
$4,023,000 |
USD |
-16% |
Q3 2025 |
Q2 2026 |
| Depreciation |
$518,000 |
USD |
-0.38% |
Q3 2025 |
Q2 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$1,250,000 |
USD |
522% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$29,480,000 |
USD |
|
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,056,000 |
USD |
-3.9% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Operating Lease, Payments |
$235,000 |
USD |
0% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
$19,024,000 |
USD |
3.7% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$701,000 |
USD |
1% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,745,000 |
USD |
-39% |
Q1 2025 |
FY 2025 |